SEQUENT SCIENTIFIC LTD.Pembelian
Buy Call For SEQUENT -- Long Term Investment
Net profit of Sequent Scientific reported to Rs 8.27 crore in the quarter ended December 2023 as against net loss of Rs 8.87 crore during the previous quarter ended December 2022. Sales declined 12.24% to Rs 329.36 crore in the quarter ended December 2023 as against Rs 375.31 crore during the previous quarter ended December 2022.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.